Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes.
about
Interpreting scores on multiple sclerosis-specific patient reported outcome measures (the PRIMUS and U-FIS)Prevalence and Incidence of Hypoglycaemia in 532,542 People with Type 2 Diabetes on Oral Therapies and Insulin: A Systematic Review and Meta-Analysis of Population Based StudiesPsychometric properties of the hypoglycemia fear survey-ii for adults with type 1 diabetes.Is hypoglycemia fear independently associated with health-related quality of life?Impact of hypoglycemia on daily life of type 2 diabetes patients in Ukraine.Medically minimising the impact of hypoglycaemia in type 2 diabetes: a review.Type 1 diabetes-associated cognitive decline: a meta-analysis and update of the current literature.The Real-Life Effectiveness and Care Patterns of Diabetes Management Study for Balkan Region (Slovenia, Croatia, Serbia, Bulgaria): A Multicenter, Observational, Cross-Sectional Study.Reliability and validity of the Treatment Satisfaction Questionnaire for Medication among Portuguese-speaking Brazilian patients with hypertension.Individual and societal consequences of hypoglycemia: A cross-sectional survey.Minimizing the risk of hypoglycemia with vildagliptin: Clinical experience, mechanistic basis, and importance in type 2 diabetes managementDetermining the minimum clinically important differences for outcomes in the DOMINO trial.Safety of once-daily insulin detemir in patients with type 2 diabetes treated with oral hypoglycemic agents in routine clinical practice.Cost-effectiveness of G5 Mobile continuous glucose monitoring device compared to self-monitoring of blood glucose alone for people with type 1 diabetes from the Canadian societal perspective.Focus group study to identify the central facets of fear of hypoglycaemia in people with Type 2 diabetes mellitus.
P2860
Q21245611-73464AD0-A8CF-4B6F-BA09-2FB7763A5A45Q28084768-4F35E21C-EB7E-4890-B005-D08995362AA7Q30427586-673E725A-7135-4B12-B0F1-3215229F96F1Q34720760-94EC97DF-7CB2-42AD-8004-63815604A688Q37017160-9AE501C1-457B-42AA-ABE9-EADB51ED9544Q37888723-7AF4490D-2F75-444C-8489-9B85D48743F6Q38231797-2A223897-878B-429F-BDDD-A1C9FBAF5FB2Q38684834-42DE139B-5FE2-475B-AB72-9515DA15E245Q38872809-E224E6A4-E305-4687-BABF-C015FB984CFAQ41740597-819BF34E-9989-4A3A-9C88-337153C6A21FQ41826517-00FB66C5-B350-49A4-B446-010DD8C630C3Q42675662-7B026608-4D9B-4258-9E6B-93C123E37026Q46758910-345F1232-1C39-4A54-B95F-21DDF6DEA0F2Q47878608-0D737942-3C19-4AF8-80BB-9DB9AB0C2F26Q48151169-1F3EE1AE-9999-401F-9262-388CADF34640
P2860
Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Fear of hypoglycaemia: definin ...... patients with type 2 diabetes.
@ast
Fear of hypoglycaemia: definin ...... patients with type 2 diabetes.
@en
type
label
Fear of hypoglycaemia: definin ...... patients with type 2 diabetes.
@ast
Fear of hypoglycaemia: definin ...... patients with type 2 diabetes.
@en
prefLabel
Fear of hypoglycaemia: definin ...... patients with type 2 diabetes.
@ast
Fear of hypoglycaemia: definin ...... patients with type 2 diabetes.
@en
P2093
P2860
P356
P1476
Fear of hypoglycaemia: definin ...... patients with type 2 diabetes.
@en
P2093
Charles M Alexander
Karl J Krobot
Tom Stargardt
P2860
P2888
P356
10.1186/1477-7525-7-91
P577
2009-10-22T00:00:00Z
P5875
P6179
1050846947